Adicet Bio (ACET)
NASDAQ:ACET
Total Valuation
Adicet Bio has a market cap or net worth of $64.20M. The enterprise value is $40.04M.
Market Cap$64.20M
Enterprise Value$40.04M
Share Statistics
Adicet Bio has 9,596,407 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,596,407
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Adicet Bio’s return on equity (ROE) is -0.73 and return on invested capital (ROIC) is -70.18%.
Return on Equity (ROE)-0.73
Return on Assets (ROA)-0.61
Return on Invested Capital (ROIC)-70.18%
Return on Capital Employed (ROCE)-0.71
Revenue Per Employee0.00
Profits Per Employee-768.44K
Employee Count152
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Adicet Bio is ―. Adicet Bio’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio0.36
Price to Fair Value0.36
Price to FCF-0.60
Price to Operating Cash Flow-0.48
PEG Ratio0.02
Income Statement
In the last 12 months, Adicet Bio had revenue of 0.00 and earned -116.80M in profits. Earnings per share was -16.95.
Revenue0.00
Gross Profit-6.38M
Operating Income-122.11M
Pretax Income-116.80M
Net Income-116.80M
EBITDA-115.73M
Earnings Per Share (EPS)-16.95
Cash Flow
In the last 12 months, operating cash flow was -95.25M and capital expenditures -1.74M, giving a free cash flow of -96.98M billion.
Operating Cash Flow-95.25M
Free Cash Flow-96.98M
Free Cash Flow per Share-10.11
Dividends & Yields
Adicet Bio pays an annual dividend of $0.01, resulting in a dividend yield of ―
Dividend Per Share$0.01
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.50
52-Week Price Change-52.75%
50-Day Moving Average7.48
200-Day Moving Average10.33
Relative Strength Index (RSI)39.35
Average Volume (3m)152.66K
Important Dates
Adicet Bio upcoming earnings date is May 12, 2026, After Close (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Adicet Bio as a current ratio of 7.47, with Debt / Equity ratio of 9.26%
Current Ratio7.47
Quick Ratio7.47
Debt to Market Cap0.00
Net Debt to EBITDA0.21
Interest Coverage Ratio-3.39K
Taxes
In the past 12 months, Adicet Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Adicet Bio EV to EBITDA ratio is -0.29, with an EV/FCF ratio of -0.35.
EV to Sales0.00
EV to EBITDA-0.29
EV to Free Cash Flow-0.35
EV to Operating Cash Flow-0.36
Balance Sheet
Adicet Bio has $158.53M in cash and marketable securities with $14.74M in debt, giving a net cash position of $143.79M billion.
Cash & Marketable Securities$158.53M
Total Debt$14.74M
Net Cash$143.79M
Net Cash Per Share$14.98
Tangible Book Value Per Share$23.10
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Adicet Bio is $38.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$38.00
Price Target Upside468.01% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast25.89%